Failure of vitamin E in clinical trials: is gamma-tocopherol the answer?

Sridevi Devaraj1, Ishwarlal Jialal

  • 1Laboratory for Atherosclerosis and Metabolic Research, Department of Pathology and Laboratory Medicine, University of California-Davis Medical Center, Sacramento, USA.

Nutrition Reviews
|September 30, 2005
PubMed

Insights

Oxidative stress and inflammation are key in atherosclerosis. Studies on alpha-tocopherol (AT) failed, possibly due to decreased gamma-tocopherol (GT), an antioxidant with anti-inflammatory effects beneficial for cardiovascular health.

Area of Science:

  • Cardiovascular Science
  • Nutritional Biochemistry
  • Oxidative Stress Research

Background:

  • Atherosclerosis pathogenesis involves oxidative stress and inflammation.
  • Clinical trials of alpha-tocopherol (AT) for cardiovascular disease prevention have been unsuccessful.
  • AT supplementation is linked to reduced levels of gamma-tocopherol (GT).

Purpose of the Study:

  • To investigate the role of gamma-tocopherol (GT) in cardiovascular disease (CVD) prevention.
  • To evaluate the therapeutic potential of GT, alone or combined with AT.
  • To understand the relationship between GT, AT, and atherosclerosis.

Main Methods:

  • Review of existing clinical trial data on AT and tocopherol levels.
  • Analysis of the antioxidant and anti-inflammatory properties of GT.
  • Correlation analysis between plasma GT levels and cardiovascular disease incidence.

Main Results:

  • Plasma GT levels are inversely associated with cardiovascular disease risk.
  • GT exhibits potent antioxidant and anti-inflammatory activities.
  • AT supplementation negatively impacts GT levels.

Conclusions:

  • Gamma-tocopherol (GT) shows promise for cardiovascular disease prevention.
  • Further research using pure GT, alone or with AT, is warranted.
  • Understanding tocopherol interactions is crucial for effective CVD prevention strategies.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...